Alps Advisors Inc Ardelyx, Inc. Transaction History

Alps Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$5.05 - $7.1 $574,068 - $807,106	-113,677 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$5.25 - $7.08 $41,013 - $55,308	-7,812 Reduced 6.43%	113,677 $597,000
Q2 2020 Aug 05, 2020	BUY	$5.37 - $8.11 $652,395 - $985,275	121,489 New	121,489 $841,000
Q4 2018 Feb 04, 2019	SELL	$1.66 - $4.16 $182,289 - $456,822	-109,813 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$3.75 - $4.65 $84,712 - $105,043	22,590 Added 25.9%	109,813 $478,000
Q2 2018 Aug 02, 2018	BUY	$3.7 - $5.8 $322,725 - $505,893	87,223 New	87,223 $323,000

218

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $799M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.